Paradigm Health
The Director of Engineering for eSource will own delivery and product strategy for Paradigm Health’s eSource offerings, partnering with product and commercial teams to define and launch the initial product and shape the longer-term technology roadmap. This role aligns engineering, data science and AI efforts to build a scalable Study Conduct platform that supports customer onboarding and drives revenue. The position also focuses on building and developing a high-performing engineering team and ensuring successful implementations and excellent user experiences.
Company Size
51-200 employees
Paradigm Health is an intelligent clinical research platform that connects and empowers patients, providers, and trial sponsors. By re‑orienting trials around patient care, it aims to make research more viable, efficient, and valuable across the ecosystem. Paradigm offers solutions for providers and sponsors (with a companion app) to improve enrollment, shorten timelines, and tackle operational hurdles that cause many studies to miss targets. The company combines technology and care‑delivery integration to accelerate discovery and deliver measurable impact.
Paradigm Health Raises $78 Million Series B to Make Clinical Trials Part of Routine Care Across the U.S. and Globally
Dec 4, 2025
Paradigm Health raises $78M, acquires Flatiron Health's Clinical Research Business
Dec 8, 2025
Paradigm Health raises $78M to revamp clinical research process, inks deal with Roche's Flatiron
Dec 4, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Paradigm Health.
Paradigm Health didn’t post a salary, so this is our estimate from similar listings.
Paradigm Health, seeking to use AI to enroll clinical trials, partners with Roche
Dec 4, 2025